This article reports the weight loss efficacy of CagriSema (cagrilintide, an amylin analogue, in combination with semaglutide, a GLP1 analogue) in adults with overweight or obesity
December 2, 2025: Another Woman Reports Losing Sight After Taking Ozempic A woman named Cilette Mitchell lost vision in both of her eyes months after she started taking Ozempic and one other GLP1 drug
This once-weekly injection makes it easier to control hunger, promoting sustainable results
Soon after, she began experiencing severe health issues, including gastrointestinal burning, stomach pain and vomiting
GLP-1 receptor activation throughout the intestinal tract can completely halt peristalsis (the wave-like muscle contractions that move food through the digestive system), creating a medical emergency requiring immediate hospitalization